Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma (Q44537656)

From Wikidata
Jump to navigation Jump to search
scientific article published in August 2003
edit
Language Label Description Also known as
English
Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma
scientific article published in August 2003

    Statements

    Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma (English)
    Martin H Kropff
    Nicola Lang
    Guido Bisping
    Nicole Dominé
    Georg Innig
    Markus Hentrich
    Manfred Mitterer
    Thomas Südhoff
    Roland Fenk
    Christian Straka
    Achim Heinecke
    Olaf M Koch
    Helmut Ostermann
    Wolfgang E Berdel
    Joachim Kienast
    1 August 2003
    607-616

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit